20. October 2022
Transglutaminase antibodies and neurological manifestations of gluten sensitivity
Read more
19. October 2021
DZG Aktuell: Aufruf zur Teilnahme an einer weiteren Wirksamkeitsstudie mit dem Studienmedikament ZED1227
Read more | Document
16. September 2020
Design of Oral FXIIIa Blockers as Safer Anticoagulants Mission Impossible?
Read more | Document
21. February 2020
Microbial transglutaminase (MTG) enables efficient and site-specific conjugation to native antibodies without the need of antibody engineering
Read more
25. September 2019
Tridegin as FXIIIa inhibitor
Read more
25. September 2017
Microbial transglutaminase: from discovery to market
Read more
6. April 2016
Tissue transglutaminase inhibitors
Read more
1. February 2016
Tissue transglutaminase in Alzheimers Disease
Read more
5. November 2015
Factor XIIIa: novel target for anticoagulation?
Read more
17. August 2015
Microbial transglutaminase for site-specific protein conjugation
Read more
1. April 2015
Transglutaminases: current research and applications - future directions
Read more

News

Blog

Events